Wells Fargo’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$825K Sell
33,222
-46,445
-58% -$1.2M ﹤0.01% 3847
2025
Q4
$2.03M Buy
79,667
+34,730
+77% +$774K ﹤0.01% 3419
2025
Q3
$724K Buy
44,937
+8,664
+24% +$140K ﹤0.01% 4039
2025
Q2
$580K Buy
36,273
+7,480
+26% +$113K ﹤0.01% 4032
2025
Q1
$492K Buy
28,793
+730
+3% +$15.3K ﹤0.01% 4109
2024
Q4
$695K Buy
28,063
+9,349
+50% +$265K ﹤0.01% 3959
2024
Q3
$534K Sell
18,714
-773
-4% -$22.8K ﹤0.01% 3953
2024
Q2
$514K Buy
19,487
+1,825
+10% +$51.9K ﹤0.01% 3893
2024
Q1
$571K Buy
17,662
+1,191
+7% +$43.5K ﹤0.01% 3802
2023
Q4
$694K Sell
16,471
-50,543
-75% -$1.86M ﹤0.01% 3656
2023
Q3
$2.57M Sell
67,014
-258
-0.4% -$5.83K ﹤0.01% 2610
2023
Q2
$1.28M Buy
67,272
+3,995
+6% +$74.5K ﹤0.01% 3279
2023
Q1
$981K Buy
+63,277
New +$1.1M ﹤0.01% 3393
2022
Q4
Sell
-123
Closed -$1K 7622
2022
Q3
$1K Sell
123
-397
-76% -$1.94K ﹤0.01% 6365
2022
Q2
$2K Buy
+520
New +$2.25K ﹤0.01% 6331
2022
Q1
Sell
-12,423
Closed -$105K 7440
2021
Q4
$105K Buy
12,423
+12,370
+23,340% +$102K ﹤0.01% 5602
2021
Q3
$0 Sell
53
-30,357
-100% -$274K ﹤0.01% 7245
2021
Q2
$321K Sell
30,410
-32,287
-51% -$451K ﹤0.01% 4835
2021
Q1
$1.01M Buy
62,697
+22,581
+56% +$595K ﹤0.01% 4245
2020
Q4
$1.85M Sell
40,116
-23,931
-37% -$1.11M ﹤0.01% 3553
2020
Q3
$2.25M Buy
64,047
+20,967
+49% +$631K ﹤0.01% 3214
2020
Q2
$1.05M Buy
+43,080
New +$923K ﹤0.01% 3778

Other funds holding IMVT